Placenta growth factor, PLGF, influences the motility of lung cancer cells, the role of Rho associated kinase, Rock1

Journal of Cellular Biochemistry

Volumn 105, Issue 1, 2008, Pages 313-320

  Chen, Jinfeng ^a   Ye, Lin ^b   Zhang, Lijian ^a   Jiang, Wen G ^b  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Lung cancer; Motility; Placental growth factor; ROCK

Indexed keywords

MESSENGER RNA; PLACENTAL GROWTH FACTOR; RHO KINASE; RHO KINASE INHIBITOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CANCER CELL; CELL MOTILITY; CONTROLLED STUDY; DRUG TARGETING; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLID TUMOR; WESTERN BLOTTING;

CELL ADHESION; CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; PREGNANCY PROTEINS; RHO-ASSOCIATED KINASES; RNA, CATALYTIC; TRANSGENES;

EID: 51849159989     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21831     Document Type: Article

References (33)

1. Ahmed A, Dunk C, Ahmad S, Khaliq A. 2000. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen - A review. Placenta 21(Suppl A): S16-S24.
2. Athanassiades A, Lala PK. 1998. Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta 19:465-473.
3. Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, Kroll J, Plaisance S, De Mol M, Bono F, Kliche S, Fellbrich G, Ballmer-Hofer K, Maglione D, Mayr-Beyrle U, Dewerchin M, Dombrowski S, Stanimirovic D, Van Hummelen P, Dehio C, Hicklin DJ, Persico G, Herbert JM, Communi D, Shibuya M, Collen D, Conway EM, Carmeliet P. 2003. Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9:936-943.
4. Casalou C, Fragoso R, Nunes JF, Dias S. 2007. VEGF/PLGF induces leukemia cell migration via P38/ERK1/2 kinase pathway, resulting in Rho GTPases activation and caveolae formation. Leukemia 21:1590-1594.
5. Castellon R, Hamdi HK, Sacerio I, Aoki AM, Kenney MC, Ljubimov AV. 2002. Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp Eye Res 74:523-535.
6. Chen CN, Hsieh FJ, Cheng YM, Cheng WF, Su YN, Chang KJ, Lee PH. 2004. The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer. Cancer Lett 213:73-82.
7. Dull RO, Yuan J, Chang YS, Tarbell J, Jain RK, Munn LL. 2001. Kinetics of placenta growth factor/vascular endothelial growth factor synergy in endothelial hydraulic conductivity and proliferation. Microvasc Res 61: 203-210.
8. Ettinger DS, Kris MG. 2001. NCCN: Non-small cell lung cancer. Cancer Control 8:22-31.
9. Giaever I, Keese CR. 1991. Micromotion of mammalian cells measured electrically. Proc Natl Acad Sci USA 88:7896-7900.
10. Hollborn M, Tenckhoff S, Seifert M, Kohler S, Wiedemann P, Bringmann A, Kohen L. 2006. Human retinal epithelium produces and responds to placenta growth factor. Graefes Arch Clin Exp Ophthalmol 244:732-741.
11. Jiang WG, Hiscox S, Hallett MB, Horrobin DF, Mansel RE, Puntis MC. 1995a. Regulation of the expression of E-cadherin on human cancer cells by gamma-linolenic acid (GLA). Cancer Res 55:5043-5048.
12. Jiang WG, Hiscox S, Hallett MB, Scott C, Horrobin DF, Puntis MC. 1995b. Inhibition of hepatocyte growth factor-induced motility and in vitro invasion of human colon cancer cells by gamma-linolenic acid. Br J Cancer 71:744-752.
13. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mokbel K, Mansel RE. 2005. Targeting matrilysin and its impact on tumor growth in vivo: The potential implications in breast cancer therapy. Clin Cancer Res 11:6012-6019.
14. Kaneko K, Satoh K, Masamune A, Satoh A, Shimosegawa T. 2002. Expression of ROCK-1 in human pancreatic cancer: Its down-regulation by morpholino oligo antisense can reduce the migration of pancreatic cancer cells in vitro. Pancreas 24:251-257.
15. Keese CR, Wegener J, Walker SR, Giaever I. 2004. Electrical wound-healing assay for cells in vitro. Proc Natl Acad Sci USA 101:1554-1559.
16. Khaliq A, Li XF, Shams M, Sisi P, Acevedo CA, Whittle MJ, Weich H, Ahmed A. 1996. Localisation of placenta growth factor (PIGF) in human term placenta. Growth Factors 13:243-250, color plates I-II, pre bk cov.
17. Khurana R, Moons L, Shaft S, Luttun A, Collen D, Martin JF, Carmeliet P, Zachary IC. 2005. Placental growth factor promotes atherosclerotic intimai thickening and macrophage accumulation. Circulation 111:2828-2836.
18. Li B, Zhao WD, Tan ZM, Fang WG, Zhu L, Chen YH. 2006. Involvement of Rho/ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells. FEBS Lett 580:4252-4260.
19. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. 1991. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88:9267-9271.
20. Marcellini M, De Luca N, Riccioni T, Ciucci A, Orecchia A, Lacal PM, Ruffini F, Pesce M, Cianfarani F, Zambruno G, Orlandi A, Failla CM. 2006. Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor. Am J Pathol 169:643-654.
21. Matsumoto K, Suzuki K, Koike H, Okamura K, Tsuchiya K, Uchida T, Takezawa Y, Kobayashi M, Yamanaka H. 2003. Prognostic significance of plasma placental growth factor levels in renal cell cancer: An association with clinical characteristics and vascular endothelial growth factor levels. Anticancer Res 23:4953-4958.
22. Parker SL, Tong T, Bolden S, Wingo PA. 1997. Cancer statistics. CA Cancer J Clin 47:5-27.
23. Parkin DM, Pisani P, Ferlay J. 1999. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80:827-841.
24. Parkin DM, Bray F, Ferlay J, Pisani P. 2001. Estimating the world cancer burden: Globocan2000. Int J Cancer 94:153-156.
25. Parr C, Watkins G, Boulton M, Cai J, Jiang WG. 2005. Placenta growth factor is over-expressed and has prognostic value in human breast cancer. Eur J Cancer 41:2819-2827.
26. Riento K, Ridley AJ. 2003. Rocks: Multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 4:446-456.
27. Rosen EM, Meromsky L, Setter E, Vinter DW, Goldberg ID. 1990. Smooth muscle-derived factor stimulates mobility of human tumor cells. Invasion Metastasis 10:49-64.
28. Shi J, Wei L. 2007. Rho kinase in the regulation of cell death and survival. Arch Immunol Ther Exp (Warsz) 55:61-75.
29. Taylor AP, Goldenberg DM. 2007. Role of placenta growth factor in malignancy and evidence that an antagonistic PIGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts. Mol Cancer Ther 6:524-531.
30. Wei SC, Tsao PN, Yu SC, Shun CT, Tsai-Wu JJ, Wu CH, Su YN, Hsieh FJ, Wong JM. 2005. Placenta growth factor expression is correlated with survival of patients with colorectal cancer. Gut 54:666-672.
31. Xu L, Cochran DM, Tong RT, Winkler F, Kashiwagi S, Jain RK, Fukumura D. 2006. Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models. Cancer Res 66:3971-3977.
32. Zhang L, Chen J, Ke Y, Mansel RE, Jiang WG. 2005. Expression of Placenta growth factor (PIGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significance. World J Surg Oncol 3:68.
33. Zuker M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406-3415.